Clinical Trials in Los Angeles

Showing 5781-5800 of 16,901 trials

Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)

NCT02103478

This first-in-human, 3-stage, open-label study evaluated the safety and pharmacokinetics of ASTX727, as well as determined the dose for later stages.

Myelodysplastic SyndromeMDS

Astex Pharmaceuticals, Inc.130 participantsStarted Oct 2014

Phoenix, Arizona, United States • Los Angeles, California, United States • Chicago, Illinois, United States +14 more locations

TERMINATEDPhase 2< 1 mile

Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

NCT02606136

This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to estimate pamrevlumab's safety and efficacy in non-ambulatory participants with DMD.

Duchenne Muscular Dystrophy

Kyntra Bio21 participantsStarted Jan 2016

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +7 more locations

Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)

Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

Find Trials by Condition in Los Angeles

Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women

SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction

Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

SGI-110 in Combination With Carboplatin in Ovarian Cancer

Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD

Benefits of Endoscopic Bariatric Procedures

Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

QUILT-3.080: NANT Pancreatic Cancer Vaccine

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

A Clinical Trial to Evaluate the Effectiveness of an Acne Serum in Improving Facial Acne and Post-Acne Pigmentation

A Clinical Trial to Evaluate the Effect of ConcenTrace Trace Mineral Drops on Gut Health

A Single Group Study to Evaluate the Effects of a Supplement on Premenstrual Syndrome

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy

A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors